Trademark Search in Canada

CONBRIZA

View On IC.GC.CA

REGISTERED

on 4 Jul 2019

Last Applicant/ Owned by

WYETH LLC

66 Hudson Boulevard EastNew York, New York 10001-2192

Serial Number

1792722 filed on 22^nd Jul 2016

Registration Number

TMA1036131 registered on 4^th Jul 2019

Registration expiry Date

4^th Jul 2029

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

M5K1N2

CONBRIZA

Trademark usage description

pharmaceutical preparations namely preparations to the treatment of menopausal and post-menopausal conditions and disorders, namely, hot flashes, vulv Read More

Classification Information

Class [005]
Pharmaceutical preparations namely preparations to the treatment of menopausal and post-menopausal conditions and disorders, namely, hot flashes, vulvar/vaginal atrophy. Pharmaceutical preparations for the prevention and treatment of osteoporosis.

Classification kind code

Mark Details

Serial Number

1792722

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 27^th Jul 2018	Allowed
Submitted for opposition 42 on 11^th Apr 2018	Advertised
Submitted for opposition 26 on 22^nd Mar 2018	Approved
Submitted for opposition 27 on 30^th Jan 2018	Approval Notice Sent
Submitted for opposition 12 on 11^th Aug 2017	Extension of Time
Submitted for opposition 22 on 8^th Feb 2017	Search Recorded
Submitted for opposition 20 on 8^th Feb 2017	Examiner's First Report
Submitted for opposition 31 on 2^th Aug 2016	Formalized
Submitted for opposition 30 on 22^nd Jul 2016	Filed
Submitted for opposition 1 on 22^nd Jul 2016	Created

CONBRIZA

Classification Information

Class [005]Pharmaceutical preparations namely preparations to the treatment of menopausal and post-menopausal conditions and disorders, namely, hot flashes, vulvar/vaginal atrophy. Pharmaceutical preparations for the prevention and treatment of osteoporosis.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations namely preparations to the treatment of menopausal and post-menopausal conditions and disorders, namely, hot flashes, vulvar/vaginal atrophy. Pharmaceutical preparations for the prevention and treatment of osteoporosis.